Can integrative oncology increase adherence to chemotherapy in advanced gynecologic cancer?

Eran Ben-AryeNaama NijkOfer LavieOrit GresselElad Schiff MdNoah Samuels

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

Patient-tailored IO programs for patients with advanced gynecological cancer may help preserve adherence to chemotherapy at 6 weeks, especially with taxane-based regimens. Further research needs to explore whether this correlation is chemotherapy agent-specific.

Keyphrases

papillary thyroid
locally advanced
case report
lymph node metastasis
type diabetes
radiation therapy
adipose tissue
childhood cancer
skeletal muscle
insulin resistance
smoking cessation
weight loss
network analysis